封面
市场调查报告书
商品编码
1386387

家禽疫苗市场报告:2030 年趋势、预测与竞争分析

Poultry Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

家禽疫苗趋势和预测

预计到 2030 年,全球家禽疫苗市场将达到 24 亿美元,2024 年至 2030 年年复合成长率为 5.1%。该市场的主要驱动力配合措施与家禽健康相关的需求不断增长、家禽中通用感染疾病的患病率增加以及遏制抗菌素抗药性的意识和努力的提高。全球家禽疫苗市场前景广阔,支气管炎、禽流感、新城疫、马立克氏症市场蕴藏商机。

家禽疫苗市场洞察

Lucintel 预测,减毒活病毒疫苗将继续成为最大的市场,因为它们具有较长的免疫力和对传染性支气管炎、传染性黏液囊炎和新城疫等禽类疾病的保护作用。

由于世界各地禽病流行率不断上升,禽流感将继续成为该市场的最大部分。

由于该地区家禽产品消费量的增加以及消费者食品安全意识的提高,北美将继续成为最大的地区。

本报告回答了 11 个关键问题:

  • Q.1. 细分市场中最有前途和高成长的机会是什么?
  • Q.2.哪个细分市场将以更快的速度成长?为什么?
  • Q.3.您认为哪些地区未来会出现更快的成长?为什么?
  • Q.4. 影响市场动态的主要因素有哪些?市场的主要挑战和商业风险是什么?
  • Q.5. 这个市场的商业风险和竞争威胁是什么?
  • Q.6.这个市场有哪些新趋势?为什么?
  • Q.7.市场客户需求有何改变?
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位?
  • Q.9.这个市场的主要企业有哪些?主要企业采取哪些策略配合措施来发展业务?
  • Q.10. 该市场上的竞争产品有哪些?由于材料或产品替代而导致市场占有率下降的威胁有多大?
  • Q.11.过去年度发生了哪些併购事件,对产业产生了哪些影响?

目录

第1章执行摘要

第2章全球家禽疫苗市场:市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第3章2018-2030年市场趋势及预测分析

  • 宏观经济趋势(2018-2023)与预测(2024-2030)
  • 全球家禽疫苗市场趋势(2018-2023)与预测(2024-2030)
  • 全球家禽疫苗市场(按产品)
    • 减毒活病毒疫苗
    • 灭活疫苗
    • 重组疫苗
  • 按疾病类型分類的全球家禽疫苗市场
    • 支气管炎
    • 禽流感
    • 新城疫
    • 马立克氏症
    • 其他的
  • 全球家禽疫苗市场按应用
    • 肉鸡
    • 蛋鸡
    • 种鸡

第4章2018-2030年分地区市场趋势及预测分析

  • 全球家禽疫苗市场区域分布
  • 北美洲家禽疫苗市场
  • 欧洲家禽疫苗市场
  • 亚太地区家禽疫苗市场
  • 其他区域家禽疫苗市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 全球家禽疫苗市场成长机会(按产品)
    • 按疾病类型分類的全球家禽疫苗市场成长机会
    • 全球家禽疫苗市场成长机会(按应用)
    • 全球家禽疫苗市场成长机会(按地区)
  • 全球家禽疫苗市场的新趋势
  • 战略分析
    • 新产品开发
    • 全球家禽疫苗市场产能扩张
    • 全球家禽疫苗市场的合併、收购与合资企业
    • 认证和许可

第7章主要企业概况

  • Bio-Vet
  • Boehringer Ingelheim
  • Ceva Animal Health
  • Elanco
  • Merck
  • Phibro Animal Health
  • Venkys
  • Zoetis
  • Vaxxinova International
  • Venkys India
简介目录

Poultry Vaccine Trends and Forecast

The future of the global poultry vaccine market looks promising with opportunities in the bronchitis, avian influenza, newcastle disease, and Marek's disease markets. The global poultry vaccine market is expected to reach an estimated $2.4 billion by 2030 with a CAGR of 5.1% from 2024 to 2030. The major drivers for this market are escalating demand for the poultry health coupled, rising prevalence of zoonotic diseases in poultry, and augmenting awareness and initiatives to curb antimicrobial resistance.

A more than 150-page report is developed to help in your business decisions.

Poultry Vaccine by Segment

The study includes a forecast for the global poultry vaccine by product, disease type, application, and region.

Poultry Vaccine Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Attenuated Live Vaccines
  • Inactivated Vaccines
  • Recombinant Vaccines

Poultry Vaccine Market by Disease Type [Shipment Analysis by Value from 2018 to 2030]:

  • Bronchitis
  • Avian Influenza
  • Newcastle Disease
  • Marek's Disease
  • Others

Poultry Vaccine Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Broiler
  • Layer
  • Breeder

Poultry Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Poultry Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies poultry vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the poultry vaccine companies profiled in this report include-

  • Bio-Vet
  • Boehringer Ingelheim
  • Ceva Animal Health
  • Elanco
  • Merck
  • Phibro Animal Health
  • Venkys
  • Zoetis
  • Vaxxinova International
  • Venkys India

Poultry Vaccine Market Insights

Lucintel forecasts that attenuated live will remain the largest segment due to its longer immunity and protection against avian diseases such as infectious bronchitis, infectious bursal disease, and newcastle disease.

Within this market, avian influenza will remain the largest segment due to the rising prevalence of avian diseases among birds across all the countries in the world.

North America will remain the largest region due to growing consumption of poultry-derived products and escalating consumer awareness towards food safety in the region.

Features of the Global Poultry Vaccine Market

Market Size Estimates: Poultry vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Poultry vaccine market size by product, disease type, application, and region in terms of value ($B).

Regional Analysis: Poultry vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, disease types, applications, and regions for the poultry vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the poultry vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the poultry vaccine market size?

Answer: The global poultry vaccine market is expected to reach an estimated $2.4 billion by 2030.

Q.2 What is the growth forecast for poultry vaccine market?

Answer: The global poultry vaccine market is expected to grow with a CAGR of 5.1% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the poultry vaccine market?

Answer: The major drivers for this market are escalating demand for the poultry health coupled, rising prevalence of zoonotic diseases in poultry, and augmenting awareness and initiatives to curb antimicrobial resistance.

Q4. What are the major segments for poultry vaccine market?

Answer: The future of the poultry vaccine market looks promising with opportunities in the bronchitis, avian influenza, newcastle disease, and Marek's disease markets.

Q5. Who are the key poultry vaccine market companies?

Answer: Some of the key poultry vaccine companies are as follows:

  • Bio-Vet
  • Boehringer Ingelheim
  • Ceva Animal Health
  • Elanco
  • Merck
  • Phibro Animal Health
  • Venkys
  • Zoetis
  • Vaxxinova International
  • Venkys India

Q6. Which poultry vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that attenuated live will remain the largest segment due to its longer immunity and protection against avian diseases such as infectious bronchitis, infectious bursal disease, and newcastle disease.

Q7. In poultry vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to growing consumption of poultry-derived products and escalating consumer awareness towards food safety in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the poultry vaccine market by product (attenuated live vaccines, inactivated vaccines, and recombinant vaccines), disease type (bronchitis, avian influenza, newcastle disease, Marek's disease, and others), application (broiler, layer, and breeder), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Poultry Vaccine Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Poultry Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Poultry Vaccine Market by Product
    • 3.3.1: Attenuated Live Vaccines
    • 3.3.2: Inactivated Vaccines
    • 3.3.3: Recombinant Vaccines
  • 3.4: Global Poultry Vaccine Market by Disease Type
    • 3.4.1: Bronchitis
    • 3.4.2: Avian Influenza
    • 3.4.3: Newcastle disease
    • 3.4.4: Marek's Disease
    • 3.4.5: Others
  • 3.5: Global Poultry Vaccine Market by Application
    • 3.5.1: Broiler
    • 3.5.2: Layer
    • 3.5.3: Breeder

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Poultry Vaccine Market by Region
  • 4.2: North American Poultry Vaccine Market
    • 4.2.2: North American Poultry Vaccine Market by Disease Type: Bronchitis, Avian Influenza, Newcastle disease, Marek's Disease, and Others
  • 4.3: European Poultry Vaccine Market
    • 4.3.1: European Poultry Vaccine Market by Product: Attenuated Live Vaccines, Inactivated Vaccines, and Recombinant Vaccines
    • 4.3.2: European Poultry Vaccine Market by Disease Type: Bronchitis, Avian Influenza, Newcastle disease, Marek's Disease, and Others
  • 4.4: APAC Poultry Vaccine Market
    • 4.4.1: APAC Poultry Vaccine Market by Product: Attenuated Live Vaccines, Inactivated Vaccines, and Recombinant Vaccines
    • 4.4.2: APAC Poultry Vaccine Market by Disease Type: Bronchitis, Avian Influenza, Newcastle disease, Marek's Disease, and Others
  • 4.5: ROW Poultry Vaccine Market
    • 4.5.1: ROW Poultry Vaccine Market by Product: Attenuated Live Vaccines, Inactivated Vaccines, and Recombinant Vaccines
    • 4.5.2: ROW Poultry Vaccine Market by Disease Type: Bronchitis, Avian Influenza, Newcastle disease, Marek's Disease, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Poultry Vaccine Market by Product
    • 6.1.2: Growth Opportunities for the Global Poultry Vaccine Market by Disease Type
    • 6.1.3: Growth Opportunities for the Global Poultry Vaccine Market by Application
    • 6.1.4: Growth Opportunities for the Global Poultry Vaccine Market by Region
  • 6.2: Emerging Trends in the Global Poultry Vaccine Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Poultry Vaccine Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Poultry Vaccine Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Bio-Vet
  • 7.2: Boehringer Ingelheim
  • 7.3: Ceva Animal Health
  • 7.4: Elanco
  • 7.5: Merck
  • 7.6: Phibro Animal Health
  • 7.7: Venkys
  • 7.8: Zoetis
  • 7.9: Vaxxinova International
  • 7.10: Venkys India